Biocatalytic drugs, including natural and artificial enzymes that can accelerate biochemical
reactions, are promising tools to address redox imbalances, metabolic disorders and …

Natural enzymes usually suffer from high production cost, ease of denaturation and
inactivation, and low yield, making them difficult to be broadly applicable. As an emerging …

The deficient catalytic activity of nanozymes and insufficient endogenous H2O2 in the tumor
microenvironment (TME) are major obstacles for nanozyme‐mediated catalytic tumor …

Cancer is one of the most severe culprits that endanger human lives. Numerous novel
nanomaterials and techniques emerge to achieve the enhanced therapeutic efficiency for …

Cell-based therapy holds great potential to address unmet medical needs and revolutionize
the healthcare industry, as demonstrated by several therapeutics such as CAR-T cell …

Current diabetic wound treatments remain difficult in clinical due to bacterial infection and
excessive reactive oxygen species (ROS). An ideal wound dressing should have prominent …

The hypoxic tumor microenvironment (TME) significantly affects cancer treatment.
Conventional chemotherapeutic agents cannot effectively target hypoxic tumor tissue, which …

Nanozymes are nanomaterials with catalytic properties similar to those of natural enzymes,
and they have recently been collectively identified as a class of innovative artificial enzymes …

Injectable functional biomaterials have made significant progress in cardiac regenerative. In
addition, how to adjust the abominable infarction microenvironment and introduce …

Most nanozymes in development for medical applications only exhibit single‐enzyme‐like
activity, and are thus limited by insufficient catalytic activity and dysfunctionality in complex …